Acute disseminated encephalomyelitis: yellow fever vaccination

A Miravalle, J Biller, E Silva, M Conneely… - Arquivos de neuro …, 2009 - SciELO Brasil
A Miravalle, J Biller, E Silva, M Conneely, P O'Keefe
Arquivos de neuro-psiquiatria, 2009SciELO Brasil
DISCUSSION YEL has been considered as one of the safest vaccine, with a very low
incidence of adverse events. The risk of vaccine-associated neurotropic (YEL-AND) disease
has been estimated as less than 8 per 1,000,000 persons 1, 2. Recent reports of post-
vaccinal encephalitis suggest that onset of neurological symptoms may occur up to 30 days
after vaccination. Clinically, YEL-AND might present as encephalitis, meningoencephalitis,
myelitis, acute disseminated encephalomyelitis (ADEM), retrobulbar optic neuritis, seizures …
DISCUSSION
YEL has been considered as one of the safest vaccine, with a very low incidence of adverse events. The risk of vaccine-associated neurotropic (YEL-AND) disease has been estimated as less than 8 per 1,000,000 persons 1, 2. Recent reports of post-vaccinal encephalitis suggest that onset of neurological symptoms may occur up to 30 days after vaccination. Clinically, YEL-AND might present as encephalitis, meningoencephalitis, myelitis, acute disseminated encephalomyelitis (ADEM), retrobulbar optic neuritis, seizures, cranial neuropathies, headaches, vertigo, paresthesias, Guillain-Barre syndrome (GBS), Fisher variant of GBS, and recently reported acute hemorrhagic fever among others. Autoimmune involvement of the central and peripheral nervous system have been proposed as a plausible pathophysiological mechanism of the disease 3-5.
SciELO Brasil
以上显示的是最相近的搜索结果。 查看全部搜索结果